💨 Abstract

The United States imposed a 27% reciprocal tariff on Indian exports, excluding pharmaceuticals. However, there are concerns that pharmaceutical products may face tariffs in future trade actions, due to the Trade Expansion Act of 1962. Indian pharmaceutical exports to the U.S., valued at $8 billion, have already reacted to the potential risk of future levies. Tariffs could drive up drug prices in the U.S.,

Courtesy: theprint.in

Summarized by Einstein Beta 🤖